Vulvar cancer study aims to end One-Size-Fits-All surgery
NCT ID NCT05576831
First seen Feb 03, 2026 · Last updated May 12, 2026 · Updated 23 times
Summary
This study looks at whether tailoring surgery for vulvar cancer based on the tumor's HPV and p53 status can reduce the chance of cancer coming back. About 249 women with early-stage vulvar squamous cell carcinoma will have their treatment guided by these markers. The goal is to avoid both over- and under-treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVAR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Vancouver Centre
RECRUITINGVancouver, British Columbia, V5Z 2E6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.